DATA SHEET

Goat anti-CHN2 Antibody

Item Number dAP-1766

Target Molecule Principle Name: CHN2; Official Symbol: CHN2; All Names and Symbols: CHN2; (chimaerin) 2; ARHGAP3; RHOGAP3; RhoGAP3; beta chimerin; Chimerin 2 (GTPase-activating , rho, 3); BCH; MGC138360; rho-GTPase-activating protein 3; Accession Number (s): NP_001035025.1; NP_004058.1; Human ID(s): 1124; Non-Human GeneID(s):

Immunogen QILIENEDVLF, is from C Terminus This antibody is expected to recognize both reported isoforms (NP_004058.1; NP_001035025.1).

Applications Pep ELISA, IHC

Species Tested: Human

Purification Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Supplied As lyophilized powder of 50ug or 100ug IgG; Reconsititute IgG with 100ul or 200ul sterile DI Water and final product will be formulated as 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing. Peptide ELISA Peptide ELISA: antibody detection limit dilution 1 to 8000.

Western Blot Western Blot: Preliminary experiments in Human Brain (Cerebellum and Frontal Cortex) lysates gave no specific signal but low background (at antibody concentration up to 1µg/ml). We would appreciate any feed- back from people in the field - have any results

IHC Immunohistochemistry: In paraffin embedded Human Cortex shows staining of neuronal bodies. Recom- mended concentration, 3-6µg/ml.

Reference Reference(s): Siliceo, M. and Merida, I. T cell receptor-dependent tyrosine phosphorylation of beta2- chimaerin modulates its Rac-GAP function in T cells. J. Biol. Chem. 284 (17), 11354-11363 (2009)..PMID: 19201754->

Optimal dilutions should be determined by each laboratory for each application. The listed dilutions are for recommendation only and the final condi- tions should be optimized by the ender users! This product is sold for Research Use Only

Angio-Proteomie | 11 Park Drive, Suite 12 Boston, MA 02215, USA | Tel: 001‐617‐549‐2665 | Fax: 001‐480‐247‐4337 | Email： [email protected]